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ABSTRACT 
Uterine positional changes can reduce the accuracy of radiotherapy for cervical cancer patients. The purpose 
of this study was to; 1) Quantify the inter-fractional uterine displacement using a novel 3D ultrasound (US) 
imaging system, and 2) Compare the result with the bone match shift determined by Cone-Beam CT (CBCT) 
imaging.Five cervical cancer patients were enrolled in the study. Three of them underwent weekly CBCT imaging 
prior to treatment and bone match shift was applied. After treatment delivery they underwent a weekly US scan. The 
transabdominal scans were conducted using a Clarity US system (Clarity® Model 310C00). Uterine positional shifts 
based on soft-tissue match using US was performed and compared to bone match shifts for the three directions. 
Mean value (±1 SD) of the US shifts were (mm); anterior-posterior (A/P): (3.8±5.5), superior-inferior (S/I) (-
3.5±5.2), and left-right (L/R): (0.4±4.9). The variations were larger than the CBCT shifts. The largest inter-
fractional displacement was from -2 mm to +14 mm in the AP-direction for patient 3. Thus, CBCT bone matching 
underestimates the uterine positional displacement due to neglecting internal uterine positional change to the bone 
structures. Since the US images were significantly better than the CBCT images in terms of soft-tissue visualization, 
the US system can provide an optional image-guided radiation therapy (IGRT) system. US imaging might be a 
better IGRT system than CBCT, despite difficulty in capturing the entire uterus. Uterine shifts based on US imaging 
contains relative uterus-bone displacement, which is not taken into consideration using CBCT bone match.  
 
1 INTRODUCTION 
Local recurrence of cervical cancer remains a challenge worldwide despite using advanced treatment techniques 
[1].  In addition to surgery and chemotherapy, radiotherapy is an effective treatment modality. However, radiation 
complications, such as gastrointestinal toxicity, are experienced by patients undergoing radiation treatment [2]. 
Modern conformal radiotherapy with tight margins and steep dose gradients, such as intensity-modulated 
radiotherapy (IMRT) and volumetric conformal arc therapy, allows a reduction of undesired radiation doses to 
healthy organs but requires more precise daily tumour alignment prior to each fraction throughout the entire course 
of the treatment. 
Today’s Image Guided Radiation Therapy (IGRT) methods, such as the electronic portal image device (EPID) 
and the kV volumetric cone beam CT (CBCT), are widely utilized for daily patient alignment and enable online 
correction of positional tumor misalignments, thereby improving the precision of the delivery of the prescribed 
radiation dose to the delineated target [3]. However, the weakness of using these ionizing system are insufficient 
soft tissue visualization, for instance in visualizing the uterus of gynecological (GYN) cancer patients or identifying 
the prostate gland and surrounding soft tissue organs at risk (OARs) in prostate cancer patients. As a result, bone 
matching is frequently applied as a daily tumor alignment method in cervical cancer treatment. For cervical cancer 
patients, large margins are applied around delineated gross tumor volume (GTV), to ensure target radiation dose 
coverage. The large margin is due to the complexity of the pelvis with its tumor and normal organ motion as well as 
deformation dynamics, which adversely impacts on the irradiated healthy tissues [4]. Additionally, tumor volume 
regression is reported to be substantial, with up to 80% reduction by the end of the treatment period [5-7]. Different 
imaging methodologies such as implanted fiducial markers as a reference point [8-10] are employed in patients with 
cervical cancer to determine uterus and/or target motion. Use of the tumor surrogate method limits analysis of 
uterine shifts, because implanted fiducial markers can fall out, migrate, or be displaced due to tumor shrinkage and 
organ deformation. On the other hand, MRI imaging provides an outstanding visualization of the uterus and cervix, 
enabling discrimination from other organs [4, 9, 11]. The application of MRI as IGRT for daily tumor alignment 
requires MRI/LINAC accessibility, which is costly and rarely used clinically [12-13]. Therefore, various cheaper 
non-ionized 3D US systems have been developed, such as the 3D Clarity® Soft Tissue Visualization system 
(Clarity® Model 310C00, Elekta, Montreal, Canada) and the NOMOS B-mode Acquisition and Targeting (BAT) 
ultrasound system [14-16]. However, these US systems can only be used for cancer sites in a soft tissue environment 
such as GYN, prostate and postoperative lumpectomy cavity in breast cancer patients. The prostate and uterus, 
where internal position variations are partly dependent on rectal-bladder filling, are ideal sites for US-scans. 
Furthermore, different uncertainty factors such as probe handling, image quality, and inter-operator variability are 
involved in the use of a US system. Inter-operator variations in US transducer probe pressure have been documented 
earlier for prostate patients [17-18]. In the present study, the main purpose was to quantify the magnitude of the 
inter-fractional uterine displacement, based on soft tissue match, using a novel 3D US imaging system. A 
specific purpose was to compare the US results with the bone match shifts determined by means of CBCT 
imaging.  
 
2  MATERIALS AND METHODS 
Five cervical cancer patients, mean age 60 years (51/68), were enrolled in this study. All underwent radiotherapy 
at Herlev hospital. One patient was excluded due to incontinence, while a second was excluded after acquisition of 
US images in the CT simulation room. The patient in question had a nephrostomy with an implanted catheter, which 
resulted in very poor image quality.Each of the patients underwent daily EPID and weekly CBCT setup verification 
imaging. Since the uterus cannot be visualized using either EPID or CBCT, all the shifts are based on bone match. 
Immediately after treatment the patients underwent a weekly US scan performed by two experienced operators. 
Seven RTTs participated in an extensive two week training program provided by the commercial vendor as well as 
several practice sessions prior to the start of the study. 
 
2.1  Clarity ultrasound system 
The Clarity ultrasound system consists of two US-units: one located in the CT simulation room and the second in 
the treatment room. The two units are connected through a workstation/server. The treatment room unit is utilized as 
intra-modality IGRT. Each US unit is equipped with a convex-probe for trans-abdominal 3D US scanning. A 
ceiling-mounted infrared (IR) camera tracks the US-probe by monitoring the IR-reflectors mounted on each probe 
(Fig. 1. A). To enable superimposition of the 3D US images of the treatment room onto the reference US image sets 
of the CT room, the US system is calibrated to the same coordinate system as the CT and treatment rooms. The 
calibration procedure is accomplished by means of a dedicated alignment phantom provided by the vendor. Quality 
assurance checks confirm the calibration on each day of use. 
 
2.2 CT-US simulation and treatment planning 
All the patients underwent a CT scan. Two radiographers with experience of the Clarity system were responsible 
for each patient. The patient alignment was performed by means of the room lasers. A US image was acquired 
immediately after the CT scan (Fig. 1.A-B). For each scan the US probe was placed in the pubic symphysis region 
and then rotated/swept followed by a probe slide in the cranial direction. This US image acquisition method is 
known as the sweep/slide technique and enables capture of the entire uterus. The sweep technique alone is a proper 
scan on prostate cancer patients, as the prostate is smaller and the entire target can be captured by a transabdominal 
sweep scan.  Firm pressure, which might lead to uterus displacement, was avoided when performing the scan, as the 
focus was on obtaining clear images to facilitate identification of the complex pelvic structure. Since the CT images 
were to be superimposed onto US images, the same patient setup is necessary for CT and US scans. All the cervical 
cancer patients underwent MRI scans after CT image acquisition. The GTVand OARs were delineated on CT-MR 
fusion image datasets by the gynecological oncologist. The CT datasets were transferred to the planning system for 
3D treatment planning.  
 
2.3 Organ delineation 
Initially the delineated target and normal structures were exported from the treatment planning system to the 
Clarity workstation. Moreover, the previously delineated bladder and rectum, based on standard MRI, were copied to 
the CT-US fusion to assist the US based target delineation. Subsequently, the CT-US image fusion was performed 
and the uterus delineated in the reconstructed 3D US-image data sets. Finally, the delineated uterus, including the 
cervix, uterine body and fundus, was approved as the Planning Reference Volume (PRV) for subsequent weekly US 
scans in the treatment room. In this study the assisted segmentation in the Clarity workstation was utilized for uterus 
delineation. Export/import from the treatment planning system to the Clarity workstation, CT/US fusion and uterus 
delineation were performed by one of two radiographers or one physicist. In addition, a single operator (MB) 
conducted a retrospective analysis of the acquired US image sets and delineated the organs. 
 
2.4 Treatment room 
The patient was prepared for daily treatment by aligning her to the lasers by means of marks on the skin, i.e. to 
reproduce the patient setup position in the CT-simulation room. In this study and prior to the treatment, the weekly 
CBCT images were acquired, and clinical alignment was performed based on bone matching. The weekly US scans 
were performed immediately after acquiring CBCT and treatment delivery. Further, the soft tissue match performed 
by superimposing the segmented uterus in the 3D US image acquired at the treatment unit onto the reference PRV 
from the CT-simulation, thus potential uterus shifts, uterine center of mass (COM) shifts, of the target were recorded. 
Finally, the correlated differences in shifts from the US and CBCT matches were compared. 
 
2.5 Statistical analysis 
A paired t-test was applied to compare US with CBCT shifts to check probability differences between the paired 
values of the two samples. This was determined by screening the variation of values within each sample and 
producing a single digit t-value. Despite the different type of image matching in this test, soft tissue versus bone 
matches, the t-test is applicable, since the aim was to investigate inter-fractional displacements using two different 
imaging modalities. Furthermore, the p-values were calculated for a 95% confidence interval (CI). Due to the low 
number of patients the t-test assumption of normal distribution must be treated with caution. 
 
3 RESULTS 
Positional uterine center of mass (COM) shifts detected by ultrasound imaging and shifts based on bone 
alignment using CBCT images in three orthogonal directions are presented in Fig. 2. Positive shifts are anterior, 
inferior and right. The figure shows 14 scans of each CBCT and US for the three patients, patient 1 five scans, 
patient 2 four scans, and patient 3 five scans. The plot reveals larger displacement shifts for US than CBCT, 
especially in the case of patient 2. This can be explained by the fact that US soft tissue matching takes uterus to bone 
shifts into account compared to only bone matching using CBCT. In this study a great effort was made to perform 
soft tissue matching based on acquired CBCT, but it was not possible due to poor image quality and thus 
discrimination of the soft tissue organs was almost impossible. As a result all the performed CBCT matches are 
based on bone match. The difference between US and CBCT can be clearly observed by examining the box-plots of 
the shifts for each patient (Fig. 3 A, B, C). These differences are obvious for patients 1 and 2 in the AP- and SI-
directions, while for patients 2 and 3 the larger deviations can be seen in the LR-direction. In the plot for the three 
patients based on a total of 14 scans, the larger deviation was visible in US scans in all three directions (Fig. 3 D). 
The overall mean (± 1SD) of the weekly uterine COM-shifts (US) and bone match shifts (CBCT) was (mm); 
US/CBCT: AP (3.8±5.5)/(2.8±2.0), SI (-3.0±5.2)/(2.8±2.0), LR (-2.7±1.7)/(-1.0±3.3), respectively (Table.1). The 
results demonstrate that inter-fractional displacements are greater with US than CBCT. The largest inter-fractional 
displacement using US was from -2 mm to +14 mm in the AP-direction for patient 3, while with CBCT the largest 
shift was from -5 mm to +5 mm in the LR-direction also for patient 3.  
The t-values and mean of differences were individually calculated for each patient, while the overall values for all 
three directions were estimated by means of the paired t-test (Table. 2). No significant differences between US and 
CBCT shifts (p > 0.05) were found in any direction, which might be explained by the low number of scans. The 
largest lower/upper range of 95% CI was in the LR-direction in patient 3 (-6.7 to +10.8). 
 
4 DISCUSSION 
Inter-fractional positional uncertainty of the uterus, rectum and bladder in GYN patients has been a challenge in 
radiotherapy, leading to the application of larger set-up margins to account for target displacement. Modern 
conformal treatment (IMRT and volumetric modulated arc therapies) enables better dose conformity, and thus 
steeper dose gradients. The delineated target and OARs are more susceptible to daily uterine positional 
displacements and rectal-bladder filling variations. These variations should be taken into account prior to each 
treatment throughout the course of treatment. The challenge involved in using CBCT and EPID, the most common 
IGRT imaging modalities today, is the difficulty identifying the soft tissue organs in the pelvis, due to the inability of 
these systems to visualize soft tissue, making it difficult to compensate for daily internal shifts. In most radiotherapy 
centers the daily target alignment of cervical cancer patients is based on bone matching, which is also standard in our 
department. However, bone matching does not take the relative uterine positional displacement into account.  
Recently, 3D US has been more frequently applied as an IGRT method and mainly used for prostate alignment prior 
to the treatment fraction [19-20]. The advantage of ultrasound imaging is believed to be the capacity of this method 
to visualize soft tissue in the pelvis, especially on the bladder-uterus and bladder-prostate intersections. Very few 
published papers have reported the application of 3D US in GYN patients [21]. The published data in this study 
mostly quantifies inter-fractional bladder motion and variations in bladder volume rather than uterine positional 
changes. For instance, in a US study of 24 patients, Ahmed et al. (2008) concluded that the bladder volume decreased 
dramatically by a mean of 71% compared to the planning CT scan. This phenomenon was also observed in our study. 
Fig. 5 illustrates the reduction in bladder volume from the start of the treatment until week 5, the final week of 
treatment, despite the fact that the patients adhered to a standard bladder-rectum filling protocol. A moderately full 
bladder provides better propagation of US-waves and hence a clearer US image by sharpening the interface between 
bladder and uterus. Bladder volume reduction presents a challenge as it affects the daily uterine and bladder position 
as well as making the use of ultrasound as a daily IGRT modality more difficult. Tumor regression during 
radiotherapy is also a challenge. In a study based on weekly CT image acquisition, Lee’s group [9] found an average 
tumor volume reduction greater than 27% in the third week compared to the initial CT planning image set.   
A number of US studies on the prostate conclude that one of the drawbacks of using 3D US such as the IGRT 
method is probe pressure induced uncertainty on the target and OARs. In one study, Chan et al.’s 2008 [4] MRI-
based study divided the uterus into three sections; cervical os, uterine canal, and uterine fundus. They reported that 
the fundus can vary from day to day by over 24 mm. Our result from patient 3 revealed an inter-fractional 
displacement of the uterine center of mass by 16 mm in the AP-direction, which supports the result of Chan et al. The 
recent study by Jurgenliemk-Schultz et al. [22], which investigated vaginal positional change and the correlation 
between vaginal shift and bladder-rectal filling, reported a daily vaginal CTV positional change of up to 23 mm in 
the AP-direction. In the present study we observed that the inter-fractional variation was larger with US than CBCT. 
This can be explained by the fact that CBCT is based on bone matching, which does not take the effect of the relative 
uterine displacement on the bone structure into account. Initially, the goal of acquiring 3D CBCT in this study was to 
perform soft tissue matches. However, the poor image quality was an obstacle to distinguishing the target from the 
organs. White et al. conducted a study [23] of inter-observer variations in delineation of the prostate, based on five 
CBCT scans performed by five genitourinary oncologists. They found that the standard deviation for volume 
determination of the prostate was 8.93 cm3 with large variability (3.98-19.00 cm3), but the average standard deviation 
for center of mass displacement was small, measuring 0.7, 1.8, and 2.8 mm in the LR, AP, and SI-directions. Despite 
disagreement about how best to delineate the prostate gland, the small inter-observer variability in COM 
displacement suggests the potential of CBCT as soft tissue image guidance, thus replacing the tumor surrogate 
method of implanted fiducial markers. However, it should be noted that the study was conducted on a small number 
of scans and the matches were performed by expert observers, which is not a clinical reality today. Since the pelvis 
of GYN patients is more complex due to multiple structures moving relative to each other as well as deformation and 
tumor regression during radiation therapy, replicating the study on GYN patients is almost impossible.  
In the present study some of the operators experienced difficulty applying the sweep/slide technique for capturing the 
entire uterus. First of all, the bladder must be identified, which is always easier in the sagittal plane and then the 
probe rotated by 90 degrees to the transversal plane, in which the scan was performed. An auto-scan probe would be 
a better solution, since after identifying the uterus in sagittal plane through a single click, the US scan and 
reconstruction of the uterine region could be conducted. Another challenge was the decrease in bladder filling during 
the treatment period, which adversely affected the image quality. This made it more difficult to identify the uterine-
bladder interface and thus inducing errors in determining the uterine position and consequently variations in the 
inter-fractional displacements. 
 
5 CONCLUSION 
US imaging might be a better IGRT system than CBCT, despite difficulty in capturing the entire uterus. Uterine 
shifts based on US imaging contains relative uterus-bone displacement, which is not taken into consideration using 
CBCT bone match. A trial study based on more patients is required to validate statistical differences between CBCT 
and US.  
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Figure 1. (A) Scanning a patient by sweeping the probe and sliding cranially. (B) The display of the US unit, where the real-time 
images can be observed. (C), (D), and (E) The fusion of acquired US images with the CT images sets to obtain a planning reference 
volume (PRV). (F) The US image, acquired in the treatment room is compared with the PRV to detect the uterine shift.   
 
 
 
Figure 2. Plot of the uterine shifts in mm (14 weekly scans of three patients) obtained by means of ultrasound imaging (soft tissue 
matches) and corresponding shifts using CBCT imaging (bone match) for the three cardinal directions; anterior-posterior (AP), 
superior-inferior (SI), and left-right (LR).  
 
 
 
 
 
  
Figure 3. (A), (B), and (C): Box-plots of uterine shifts based on CBCT bone matches and US soft tissue matches for the three patients 
in the three cardinal directions; LR, AP, and SI. (D): The overall shifts for the patients in all directions. 
 
Table. 1 The overall mean (3 patients, 14 scans), median, and standard deviations of the uterine inter-fractional shifts for ultrasound 
and CBCT matches in all three directions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Ultrasound CBCT 
 Anterior/ 
Posterior 
Superior/ 
Inferior 
Left/ 
Right 
Anterior/ 
Posterior 
Superior/ 
Inferior 
Left/ 
Right 
Median 4.6 -3.2 2.2 3.0 -3.0 -0.5 
Mean 
(±1SD) 
3.8 (±5.5) -3.0 (±5.2) 0.4 (±4.9) 2.8 (±2.0) -2.7 (±1.7) -1.0 (±3.3) 
 
Table2. Values of paired t-test of obtained matching shifts using weekly ultrasound and CBCT scans of cervical cancer patients.  
The p-values are calculated for a 95% confidence interval (CI). 
  N Mean 
Of 
diff. 
df t 95% CI 
(lower/upper) 
P-value 
 Direction       
Patient 
1 
Anterior-
Posterior 
5 -0.92 4 -
0.43 
-6.93/5.09 0.692 
Superior-
Inferior 
5 1.64 4 0.72 -4.65/7.93 0.509 
Left-Right 5 2.4 4 2.74 -0.03/4.83 0.052 
        
Patient 
2 
Anterior-
Posterior 
4 1.40 3 0.57 -6.35/9.15 0.606 
Superior-
Inferior 
4 -2.68 3 -
1.22 
-9.66/4.31 0.310 
Left-Right 4 -0.55 3 -
2.67 
-7.11/6.01 0.807 
        
Patient 
3 
Anterior-
Posterior 
5 2.67 4 1.41 -2.57/7.92 0.230 
Superior-
Inferior 
5 -0.49 4 -
0.28 
-5.39/4.40 0.793 
Left-Right 5 2.05 4 0.65 -6.74/10.85 0.552 
        
Three 
patients 
Anterior-
Posterior 
14 1.03 13 0.84 -1.60/3.65 0.414 
Superior-
Inferior 
14 -0.36 13 -
0.29 
-2.96/2.25 0.773 
Left-Right 14 1.43 13 1.14 -1.29/4.16 0.276 
 
 
 
Figure. 5 The bladder volume reduction in patient 1 from week 2 to week 5 of treatment.       
 
 
